is reporting from
Member
NP Rank:
NP Rank:
Health official in Japan say that a they have found a second case of a swine flu patient being resistant to Tamiflu, the most effective antiviral drug used to fight the disease.
The patient - a woman in Osaka prefecture - was recovering after having been given Ralenza, an alternative anti-flu medication, the Kyodo news agency reported.
Earlier this week a Danish swine flu patient was found to be resistant to Tamiflu.
First H1N1 swine flu patient was found to be resistant to Tamiflu (Oseltamivir) treatment in Denmark.
Swiss pharmaceuticals giant Roche is claiming that this is in fact normal and nothing to panic about.
"It is absolutely normal," she said, adding that "0.4 per cent of adults develop resistance" to Tamiflu.
She said the case does not indicate Tamiflu has become less effective against swine flu.
Most RecentMost Recommended Comments (1)
at 20:40 on September 10th, 2009
We surely would not want the Gilead Sciences stock value (Tamiflu) to take a hit in the event it was discovered that Tamiflu was less effective than Ralenza. Screw the people - it's the shareholders that matter. Our previous Secretary of Defense saw to it that the stock went up while stock-piling Tamiflu for our troops ---- and he made a killing on it!!